[Clinical evaluation of TANDEM PSA in Japanese cases and comparison with other methods].
Clinical evaluation of TANDEM PSA which is the most frequently used prostate specific antigen (PSA) assay method in the world and a comparison with other methods were performed in Japanese cases in a cooperative research fashion. The minimum detectable level of the method was found to be 0.50 ng of PSA in one ml of serum and 1.9 ng/ml was regarded as the upper normal value in Japanese males. The distribution of serum PSA showed a significant difference between the benign prostate hypertrophy (BPH) cases and patients with stage C or D prostate cancer. The sero-diagnosis prostate cancer at an early stage with the TANDEM PSA was difficult. The correlation to other methods of PSA detection was very high. Furthermore, the clinical use of the method in following-up the clinical course of prostate cancer patients was very useful. These findings suggested that the PSA detection using TANDEM PSA is applicable even in Japanese cases although the upper cut-off level is decreased.
Kuriyama
M
M
Department of Urology, Gifu University School of Medicine.
Yamamoto
N
N
Shinoda
I
I
Kawada
Y
Y
Akimoto
S
S
Shimazaki
J
J
D000368:Aged; D000369:Aged, 80 and over; D005069:Evaluation Studies as Topic; D006801:Humans; D015592:Immunoradiometric Assay; D007564:Japan; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000276:immunology; D011933:Reagent Kits, Diagnostic / Q000592:standards; D012044:Regression Analysis
D011933:Reagent Kits, Diagnostic; D017430:Prostate-Specific Antigen